Terence N. Bukong, Wei Hou, Karen Kodys, Gyongyi Szabo – 16 August 2012 – Alcohol use and hepatitis C virus (HCV) infection synergize to cause liver damage, and microRNA‐122 (miR‐122) appears to play a key role in this process. Argonaute 2 (Ago2), a key component of the RNA‐induced silencing complex (RISC), has been shown to be important in modulating miR‐122 function during HCV infection. However, GW182, a critical component of processing bodies (GW bodies) that is recruited by Ago2 to target messenger RNA (mRNA), has not been assessed in HCV infection.

Ralf Bahde, Sorabh Kapoor, Sriram Bandi, Kuldeep K. Bhargava, Christopher J. Palestro, Sanjeev Gupta – 16 August 2012 – To optimize strategies for liver‐directed cell therapy, prevention of initial transplanted cell losses is particularly important for subsequent liver repopulation. After cell transplantation in hepatic sinusoids, perturbations in hepatic microcirculation along with changes in various liver cell types are among the earliest changes.

Kun Wu, Jin Ding, Cheng Chen, Wen Sun, Bei‐Fang Ning, Wen Wen, Lei Huang, Tao Han, Wen Yang, Chao Wang, Zhong Li, Meng‐Chao Wu, Gen‐Sheng Feng, Wei‐Fen Xie, Hong‐Yang Wang – 16 August 2012 – Liver cirrhosis is a predominant risk factor for hepatocellular carcinoma (HCC). However, the mechanism underlying the progression from cirrhosis to HCC remains unclear. Herein we report the concurrent increase of liver progenitor cells (LPCs) and transforming growth factor‐β (TGF‐β) in diethylnitrosamine (DEN)‐induced rat hepatocarcinogenesis and cirrhotic livers of HCC patients.

Dahee Choi, Kyoung‐Jin Oh, Seung‐Hoi Koo – 13 August 2012

Tokuzo Arao, Kazuomi Ueshima, Kazuko Matsumoto, Tomoyuki Nagai, Hideharu Kimura, Satoru Hagiwara, Toshiharu Sakurai, Seiji Haji, Akishige Kanazawa, Hisashi Hidaka, Yukihiro Iso, Keiichi Kubota, Mitsuo Shimada, Tohru Utsunomiya, Masashi Hirooka, Yoichi Hiasa, Yoshikazu Toyoki, Kenichi Hakamada, Kohichiroh Yasui, Takashi Kumada, Hidenori Toyoda, Shuichi Sato, Hiroyuki Hisai, Teiji Kuzuya, Kaoru Tsuchiya, Namiki Izumi, Shigeki Arii, Kazuto Nishio, Masatoshi Kudo – 13 August 2012 – The response rate to sorafenib in hepatocellular carcinoma (HCC) is relatively low (0.7%‐3%), however, rapid and d

B. Joseph Elmunzer, Anthony T. DeBenedet, Michael L. Volk, Christopher J. Sonnenday, Akbar K. Waljee, Robert J. Fontana, Aarti B. Oza, Amit Singal, Michael J. Englesbe, James M. Scheiman – 10 August 2012 – Diagnostic endoscopic retrograde cholangiopancreatography (D‐ERCP) is commonly performed for the evaluation of biliary complications after orthotopic liver transplantation (OLT). This practice is contrary to the national trend of reserving endoscopic retrograde cholangiopancreatography (ERCP) for therapeutic purposes.

Aya Miyagawa‐Hayashino, Atushi Yoshizawa, Yoichiro Uchida, Hiroto Egawa, Kimiko Yurugi, Satohiro Masuda, Sachiko Minamiguchi, Taira Maekawa, Shinji Uemoto, Hironori Haga – 10 August 2012 – The role of donor‐specific anti‐human leukocyte antigen antibodies (DSAs) that develop late after living donor liver transplantation is unknown. Seventy‐nine pediatric recipients who had good graft function and underwent protocol liver biopsy more than 5 years after transplantation (median = 11 years, range = 5‐20 years) were reviewed.

Steven C. Rose, Steven G. Kikolski, Robert G. Gish, Yuko Kono, Rohit Loomba, Alan W. Hemming, Michael J. Wallace, On behalf of the Society of Interventional Radiology – 10 August 2012

Kevin Moore – 10 August 2012

Robert H. Squires, Anil Dhawan, Estella Alonso, Michael R. Narkewicz, Benjamin L. Shneider, Norberto Rodriguez‐Baez, Dominic Dell Olio, Saul Karpen, John Bucuvalas, Steven Lobritto, Elizabeth Rand, Philip Rosenthal, Simon Horslen, Vicky Ng, Girish Subbarao, Nanda Kerkar, David Rudnick, M. James Lopez, Kathleen Schwarz, Rene Romero, Scott Elisofon, Edward Doo, Patricia R. Robuck, Sharon Lawlor, Steven H.